0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

A Different Perspective Regarding Prostate-Specific Antigen Testing

Paul Ross Casner, MD, PhD
Arch Intern Med. 2012;172(14):1110-1114. doi:10.1001/archinternmed.2012.2038.
Text Size: A A A
Published online

Extract

I wish to provide a different perspective regarding prostate-specific antigen (PSA) testing and prostate cancer to the one reported by Dr Bennet.1 I was diagnosed as having prostate cancer at a similar age to Dr Bennet (57 years) some 6 years ago. I had routinely checked my PSA on a yearly basis, and it was typically around 2.0 ng/mL (to convert to micrograms per liter, multiply by 1). When retested it went up to 3.3 ng/mL, an unusual increase compared with my previous values but still within what was considered the “normal range.” Despite that, I was concerned about the sudden increase. I had symptoms of benign prostatic hyperplasia, and my father had prostate cancer in his mid 70s. I decided to consult a urologist colleague. On examination, my prostate was slightly asymmetric but without nodules. My urologist told me it was very unlikely to have prostate cancer but recommended a biopsy because of my family history. One of 10 biopsy specimens was reported positive for prostate cancer, with a Gleason score of 6 (3 + 3).

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

July 23, 2012
Deborah Grady, MD, MPH; Rita F. Redberg, MD, MSc
Arch Intern Med. 2012;172(14):1110-1114. doi:10.1001/archinternmed.2012.2637.
CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 1

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();